Xue Qun Ren

TL;DR: This rapid advice guideline is suitable for the first frontline doctors and nurses, managers of hospitals and healthcare sections, community residents, public health persons, relevant researchers, and all person who are interested in the 2019-nCoV.

TL;DR: This letter provided the newest diagnostic criteria of “suspected case’ and “confirmed case” according to the latest Diagnosis and Treatment Guidelines for COVID-19 (seventh version) that issued by the National Health Committee of the People’s Republic of China.

TL;DR: The CYP1A1 Ile462Val polymorphism may enhance the susceptibility to cervical cancer in Caucasian females, and after subgroup analyses based on ethnicity and source of control, the polymorphism increased the susceptibility of cervical cancer.

TL;DR: The seven versions of China's national guidelines are analyzed to examine how the diagnostic criteria roadmap has developed and evolved, in order to share the experience worldwide and provide suggestions for worldwide understanding and management of this pandemic.

TL;DR: The quality of CO VID-19 related studies needs to be improved by strengthening the registration process and improving the quality of clinical study protocols so that these clinical studies can provide high-quality clinical evidence related to COVID-19.